We gave our competitors our HIV sources. Here’s why
Newsrooms compete for stories, audiences and money. But for two days, we tried something different: Bhekisisa shared what we've learned about the six-monthly HIV prevention injection, lenacapavir, with journalists who are usually our competitors. Here’s why I think we need to do more of it. The post We gave our competitors our HIV sources. Here’s why appeared first on Bhekisisa .
News outlets vie for attention, resources, and story breakthroughs. Bhekisisa, a South African health journalism outlet, shared expertise and sources on lenacapavir (LEN), a six-month HIV prevention injection introduced in state clinics, with 10 competitors. Journalists need more than press releases to cover complex health topics; they require time with scientists, health workers, data, and people using the health system.
Bhekisisa's workshop aimed to deepen understanding of LEN, sharing science, roll-out, and access to researchers, data, and sources. LEN's complexities include accessibility, demand, health worker decisions, scaling, and affordability. Workshop participants engaged with health department data, modelling scientists, and implementation studies.
Post-workshop, journalists visited a clinic to witness LEN's roll-out and interviewed four LEN users to capture their firsthand experiences.
Written by urgent.news from Bhekisisa's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
